A Spray-Drying Method for Mass Production of Liposomes
スポンサーリンク
概要
- 論文の詳細を見る
A spray-drying method for the mass production of liposomes was developed : lipids were dissolved in a volatile organic solvent such as chloroform in which, in some cases, a core material such as mannitol was additionally suspended, and the organic solution or suspension was then spray-dried. Addition of core material particles or the use of hydrogenated lecithins increased the recovery of the lipid mixture prepared by spray-drying. Since the obtained spray-dried product was very amorphous, it could be easily hydrated with an aqueous solution, and lipid vesicles (lisopomes) were spontaneously formed by agitating. These spray-dried (SD) liposomes were characterized in comparison with the traditional liposomes known as Bangham's liposomes.Incorporation of cholesterol into the SD-liposomal membrane was confirmed by differential scanning calorimetry and gel filtraiton chromatography. Incorporation of charged lipids was confirmed by the zeta potential of liposomes.The size distribution of the unextruded SD-liposomes was similar to that of Bangham's liposomes, and a more homogeneous size distribution could be obtained by the extrusion technique. When glucose and dextran were used as water-soluble model drugs, the encapsulation efficiency was 15-65% depending on the total lipid concentration. Increasing the practical surface area of the lipid mixture using a core material was considered to cause a noticeably high encapsulation efficiency of dextran into the SD-liosomes.This spray-drying method was found to be useful and valuable for the mass production of liposomes.
- 公益社団法人日本薬学会の論文
- 1991-06-25
著者
-
菊池 寛
第一製薬(株)研究開発本部創剤代謝研究所
-
菊池 寛
第一製薬株式会社・創剤代謝研究所
-
広田 貞雄
Pharmaceutical Formulation Research Center Research Institute Daiichi Pharmaceutical Co. Ltd. :(pres
-
菊池 寛
Pharmaceutical Formulation Research Center Research Institute Daiichi Pharmaceutical Co. Ltd.
-
山内 仁史
ニプロパッチ研究開発部
-
山内 仁史
埼玉第一製薬(株)研究部
-
山内 仁史
Pharmaceutical Formulation Research Center, Research Institute, Daiichi Pharmaceutical Co., Ltd.
-
山内 仁史
Pharmaceutical Formulation Research Center Research Institute Daiichi Pharmaceutical Co. Ltd.
関連論文
- ミトコンドリアを標的としたDDSと疾患治療への応用 : ミトコンドリア融合性リポソーム、"MITO-Porter" を用いたアプローチ
- 人工ベクターによる導入遺伝子の核内移行及び発現メカニズム(2)
- 人工ベクターによる導入遺伝子の核内移行及び発現メカニズム(1)
- DDSの夢(DDS)
- O6-010 高含水シート適用後の皮膚水和作用(一般演題 口頭発表,薬物療法/持参薬管理/栄養管理・NST/健康食品サプリメント,医療薬学の創る未来 科学と臨床の融合)
- ナノDDSとしてのリポソーム医薬品 : 現状と今後の展望(セミナー)
- 癌化学療法剤含有リポソーム投与時におけるマクロファージの役割は?
- ナノパーティクルの粘膜付着性に起因するカルシトニンの吸収改善
- Microdialysis 法によるフェルビナク貼付剤の薬物浸透性及び薬理効果に関する研究
- Characteristics of transdermal topical delivery patch (MILTAX^【〇!R】) containing the anti-inflam-matory and analgestic drug, ketoprofen
- ブクラデシン軟膏の改良に関する研究(第一報) : 易使用化の試み
- ハイドロダイナミックス (hydrodynamics) を利用した新規カチオニックリポソームTFLによる生体内遺伝子送達に関する研究
- 技術賞 ポリアクリル酸-アルミニウム架橋高分子ゲルを用いたケトプロフェン貼付剤(ミルタックス)の開発
- ブラクデシン軟膏の改良に関する研究(第二報) : 他剤との配合変化試験
- メロキシカムの皮膚透過性に及ぼす吸収促進剤の併用効果
- 界面活性剤のゲル中における構造様式
- Effect of Crystallinity on the Percutaneous Absorption of Corticosteroid. II. Chemical Activity and Biological Activity
- Effect of Crystallinity on the Percutaneous Absorption of Corticosteroid. I. Determination of the Degree of Crystallinity of Hydrocortisone Acetate in Ground Mixtures with Crystalline Cellulose
- Estimation of the Degree of Crystallinity and the Disorder Parameter in a Drug by an X-Ray Diffraction Method with a Single Sample
- A Spray-Drying Method for Mass Production of Liposomes
- Possibility of Heat Sterilization of Liposomes
- Texture Study on Optimum Formulation of Molded Poultices
- W/O型抗炎症エマルジョン製剤のコロイド化学的安定性に関する誘電的研究
- Effects of Particle Size and Stabilizing Agents upon Dielectric Properties of Water-in-Oil Type Emulsions
- Dielectric Studies of Emulsions of Polyol in Hydrophobic Colloidal Silica-Oil Gel
- Dielectric Studies on Emulsion of Aqueous Agarose Gel in Hydrophobic Colloidal Silica-Oil Gel
- Fused 1,3-Oxazine Derivatives. Synthesis of 2H-1,3-Oxazino [5,6-b]-quinoxaline-2,4 (3H)-diones (1-Oxaalloxazines), 2H-1,3-Oxazino-[6,5-b] quinoline-2,4 (3H)-diones (5-Deaza-1-oxaalloxazines), and 2H-Pyrido [3,2-e]-1,3-oxazine-2,4 (3H)-diones
- Dielectric Studies on Emulsion of Water in Hydrophobic Colloidal Silica-Oil Gel. II
- Dielectric Studies on Emulsion of Water in Hydrophobic Colloidal Silica-Oil Gel
- Stability of Ascorbic Acid in Fused System Containing Ascorbic Acid and Mannitol
- Estimation of the Shelf Life of a Drug in Its Solid State. II. A Proposition for a New Kinetical Equation of Gas-Solid Reactions for Pharmaceutical Solids
- Estimation of the Shelf Life of a Drug in Its Solid State. I. An Application of Lacey's Theory to a Kinetic Analysis of an Air Oxidation of Ascorbic Acid in Its Solid State
- DDS医薬品の実用化のために克服すべき問題点 : リポソームを例として
- 将来ビジョン委員会報告 : これまでの活動をふり返って
- 企業から見たDDS研究の変遷と今後の展望
- リポソーム製剤化技術 : 遺伝子導入用リポソームの調製に際して
- DDSによる医療への貢献を夢見て : 創剤研究者としてのアプローチ
- 微粒子製剤設計とDDS - 夢から現実へ -
- 患者の QOL (Quality of Life) 向上を目指したパップ剤の有用性
- 高付加価値製剤に関する最近の話題
- 医薬品分野におけるナノテクノロジーの応用 (特集/ナノテクノロジーと香粧品科学)
- 天然界面活性物質の界面化学的性質とそのドラッグデリバリーシステムへの応用
- 抗炎症鎮痛薬ケトプロフェンを含有する経皮吸収製剤(MILTAX®)の特徴
- ツロブテロールの透過性における貼付剤の種類と皮膚特性の影響--結晶を溶解するトリグリセリドの重要性
- A simple and easy method for determination of meloxicam in rat muscle and plasma